Novel method for studying photolability of topical formulations: A case study of titanium dioxide stabilization of ketoprofen

Journal of Pharmaceutical Sciences

Volumn 94, Issue 4, 2005, Pages 781-787

  Lodén, Marie ^a   Åkerström, Ulf ^a   Lindahl, Karin ^a,b   Berne, Berit ^c  

^a Box 622   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Particle size; Skin; Stability; Toxicity; UV vis spectroscopy

Indexed keywords

DRUG; EXCIPIENT; HOMBIKAT; KETOPROFEN; NANOPARTICLE; TIOVEIL AQ N; TITANIUM DIOXIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG DECOMPOSITION; DRUG DETERMINATION; DRUG FORMULATION; DRUG STABILITY; FEMALE; GEL; HUMAN; HUMAN TISSUE; MALE; MATERIAL COATING; NORMAL HUMAN; PROTECTION; SKIN MANIFESTATION; SKIN SURFACE; STRATUM CORNEUM; SUNLIGHT; SURFACE PROPERTY; TECHNIQUE; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

EID: 17744394324     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.20295     Document Type: Article

References (27)

1. Tonnesen HH. 2001. Formulation and stability testing of photolabile drugs. Int J Pharm 225:1-14.
2. Kakinoki K, Yamane K, Teraoka R, Otsuka M, Matsuda Y. 2004. Effect of relative humidity on the photocatalytic activity of titanium dioxide and photostability of famotidine. J Pharm Sci 93:582-589.
3. Gould JW, Mercurio MG, Elmets CA. 1995. Cutaneous photosensitivity diseases induced by exogenous agents. J Am Acad Dermatol 33:551-573; quiz 574-556.
4. Bagheri H, Lhiaubet V, Montastruc JL, Chouini-Lalanne N. 2000. Photosensitivity to ketoprofen: Mechanisms and pharmacoepidemiological data. Drug Saf 22:339-349.
5. Kaidbey K. 1998. The evaluation of photoallergic contact sensitizers in humans. Washington, DC: Taylor & Francis, pp 251-258.
6. SCCNFP opinion concerning titanium dioxide, Colipa n S75 adopted by the SCCNFP during the 14th plenary meeting of 24 October 2000. Scientific Committee on Cosmetic Products and Non-food Products intended for Consumers, http:// europaeuint/comm/food/fs/sc/sccp/out135_enhtml.
7. Warner WG, Yin JJ, Wei RR. 1997. Oxidative damage to nucleic acids photosensitized by titanium dioxide. Free Radic Biol Med 23:851-858.
8. Lademann J, Weigmann H, Schafer H, Muller G, Sterry W. 2000. Investigation of the stability of coated titanium microparticles used in sunscreens. Skin Pharmacol Appl Skin Physiol 13:258-264.
9. Bosca F, Miranda MA, Carganico G, Mauleón D. 1994. Photochemical and photobiological properties of ketoprofen associated with the benzophenone chromophore. Photochem Photobiol 60:96-101.
10. Moore RA, Tramer MR, Carroll D, Wiffen PJ, McQuay HJ. 1998. Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ 316:333-338.
11. SADRAC. 1998. Ketoprofen gel contact dermatitis and photosensitivity. Bulletin Swedish Adverse Drug Reactions Advisory Committee (SADRAC).
12. Baudot S, Milpied B, Larousse C. 1998. Cutaneous side effects of ketoprofen gels: Results of a study based on 337 cases. Therapie 53:137-144.
13. Brisaert M, Plaizier-Vercammen J. 2000. Investigation on the photostability of a tretinoin lotion and stabilization with additives. Int J Pharm 199:49-57.
14. McKenna KE, Stern RS. 1995. Photosensitivity associated with combined UV-B and calcipotriene therapy. Arch Dermatol 131:1305-1307.
15. Thoma K, Kubler N, Reimann E. 1997. The photostability of antimycotics. 3. Photostability of locally acting antimycotics. Pharmazie 52:362-373.
16. Cirunay JJ, Vander Heyden Y, Plaizier-Vercammen J. 2001. LC separation of calcipotriol from its photodegradation products and protection possibilities using adjuvants. J Pharm Biomed Anal 26: 31-41.
17. Berne B, Ros AM. 1998. Seven years experience of photopatch testing with sunscreen allergens in Sweden. Contact Dermatitis 38:61-64.
18. Stokes R, Diffey B. 1999. In vitro assessment of sunscreen photostability: The effect of radiation source, sunscreen application thickness and substrate. Int J Cosmet Sci 21:341-351.
19. Berset G, Gonzenbach H, Christ R, Martin R, Deflandre A, Mascotto RE, Jolley JDR, Lowell W, Pelzer R, Stiehm T. 1996. Proposed protocol for determination of photostability. Part I: Cosmetic UV filters. Int J Cosmet Sci 18:167-177.
20. Ivens UI, Steinkjer B, Serup J, Tetens V. 2001. Ointment is evenly spread on the skin, in contrast to creams and solutions. Br J Dermatol 145:264-267.
21. Loden M, Lindahl K, Åkerström U, Berne B. 2004. Bioequivalence determination of topical ketoprofen using a dermatopharmacokinetic approach and excised skin penetration. Int J Pharm 284:23-30.
22. Moyal D, Refregier JL, Chardon A, 2002. In vivo measurement of the photostability of sunscreen products using diffuse reflectance spectroscopy. Photodermatol Photoimmunol Photomed 18:14-22.
23. Cosa G, Martinez LJ, Scaiano JC. 1999. Influence of solvent polarity and base concentration of the photochemistry of ketoprofen: Independent singlet and triplet pathways. Phys Chem Chem Phys 1: 3533-3537.
24. Radschuweit A, Ruttinger HH, Nuhn P, Wohlrab W, Huschka C. 2001. UV-induces formation of hydrogen peroxide based on the photochemistry of ketoprofen. Photochem Photobiol 73:119-127.
25. Thiele JJ, Weber SU, Packer L. 1999. Sebaceous gland secretion is a major physiologic route of vitamin E delivery to skin. J Invest Dermatol 113: 1006-1010.
26. Thiele JJ, Schroeter C, Hsieh SN, Podda M, Packer L. 2001. The antioxidant network of the stratum corneum. Curr Probl Dermatol 29:26-42.
27. Pflucker F, Wendel V, Hohenberg H, Gartner E, Will T, Pfeiffer S, Wepf R, Gers-Barlag H. 2001. The human stratum corneum layer: An effective barrier against dermal uptake of different forms of topically applied micronised titanium dioxide. Skin Pharmacol Appl Skin Physiol 14(Suppl 1):92-97.